ELOX - Company ID 0001035354
The table below shows Eloxx Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.79M | $19.21M | $42.27M | $24.67M | $22.49M | $48.61M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.27M |
| $20.13M |
| $43.48M |
| $25.89M |
| $57.71M |
| $50.34M |
| Property, plant & equipment | $0.00 | $169.00K | $216.00K | $133.00K | $201.00K | $248.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $5.27M | $21.12M | $45.14M | $26.48M | $58.95M | $50.72M |
| Accounts payable | $2.71M | $3.02M | $1.38M | $481.00K | $1.87M | $747.00K |
| Total current liabilities | $17.18M | $23.09M | $9.96M | $9.84M | $11.81M | $7.81M |
| Long-term debt | $0.00 | $8.56M | $12.00M | $6.38M | $10.50M | - |
| Total liabilities | $17.18M | $31.78M | $22.75M | $16.25M | $22.73M | - |
| Retained earnings | -$300.58M | -$274.39M | -$238.32M | -$171.60M | -$137.02M | -$86.14M |
| Total equity | -$11.91M | -$10.66M | $22.38M | $10.23M | $36.21M | $42.91M |